NSCI is pleased to announce our successful IND application to the FDA that will enable clinical testing of a novel stem cell therapy for patients with age-related macular degeneration (AMD). In AMD, the retinal pigment epithelial cells (RPE) at the back of the eye degenerate, causing loss of …
Neural Stem Cell Institute, Rensselaer NY
Stem cell research and applications in the treatment of diseases like Retinitis Pigmentosis, Alzheimer's, Parkinson's, Spinal Cord Injury, Retinal Degeneration. Home of SallyTemple's lab.